Variant report
Variant | nsv564747 |
---|---|
Chromosome Location | chr14:46807798-46836326 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572223912 | chr14:46813075-46813076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190736589 | chr14:46813088-46813089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146046821 | chr14:46813089-46813090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531582381 | chr14:46813093-46813094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549857576 | chr14:46813105-46813106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561778630 | chr14:46813109-46813110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528861536 | chr14:46813146-46813147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72670527 | chr14:46813182-46813183 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs114102156 | chr14:46813215-46813216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368532187 | chr14:46813235-46813236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534215976 | chr14:46813242-46813243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552877470 | chr14:46813270-46813271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542971132 | chr14:46813330-46813331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113482604 | chr14:46813336-46813337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538058065 | chr14:46813375-46813376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563865161 | chr14:46813392-46813393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374536431 | chr14:46813393-46813394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556205404 | chr14:46813457-46813458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574613367 | chr14:46813521-46813522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368495680 | chr14:46813524-46813525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200106734 | chr14:46813578-46813579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566652350 | chr14:46813584-46813585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538443003 | chr14:46813593-46813594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182090576 | chr14:46813629-46813630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144171394 | chr14:46813791-46813792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371822280 | chr14:46813817-46813818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376605466 | chr14:46813823-46813824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533845751 | chr14:46813855-46813856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543660099 | chr14:46813861-46813862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368994245 | chr14:46813867-46813868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4424814 | chr14:46813895-46813896 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs567257486 | chr14:46813954-46813955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559081499 | chr14:46813978-46813979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576242838 | chr14:46814882-46814883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538462543 | chr14:46814906-46814907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573837122 | chr14:46814911-46814912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541234727 | chr14:46814917-46814918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574339209 | chr14:46814919-46814920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552764169 | chr14:46814924-46814925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577645543 | chr14:46814984-46814985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558293537 | chr14:46814996-46814997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562935238 | chr14:46814997-46814998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530471596 | chr14:46815045-46815046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145523689 | chr14:46815060-46815061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182421633 | chr14:46815079-46815080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374085477 | chr14:46815096-46815097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568619584 | chr14:46815104-46815105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547994762 | chr14:46815148-46815149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141180818 | chr14:46815243-46815244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572228252 | chr14:46815252-46815253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:46813000-46814000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr14:46813600-46814000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr14:46814800-46815800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr14:46818800-46821200 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |